Paper36980267
Biology of Cancer-Testis Antigens and Their Therapeutic Implications in Cancer.
Nin DS and 1 other. Cells, 2023. Cited by 54 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Biology of Cancer-Testis Antigens and Their Therapeutic Implications in Cancer. Papers, record 36980267. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36980267
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Testis | Major topic |
| Neoplasms | Major topic |
| Male | |
| Humans | |
| Antigens, Neoplasm | |
| Carcinogenesis | |
| Biology |
Source PubMed
References230
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35347116 | The cancer/testis antigen HORMAD1 mediates epithelial-mesenchymal transition to promote tumor growth and metastasis by activating the Wnt/β-catenin signaling pathway in lung cancer. | Cell Death Discov | 2022 | https://conductscience.org/library/papers/35347116 | PubMed |
| 2 | 14659893 | The TPTE gene family: cellular expression, subcellular localization and alternative splicing. | Gene | 2003 | https://conductscience.org/library/papers/14659893 | PubMed |
| 3 | 1067619 | Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells. | Proc Natl Acad Sci U S A | 1976 | https://conductscience.org/library/papers/1067619 | PubMed |
| 4 | 27377895 | A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis. | Nat Commun | 2016 | https://conductscience.org/library/papers/27377895 | PubMed |
| 5 | 29656892 | Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 Blockade. | Cell | 2018 | https://conductscience.org/library/papers/29656892 | PubMed |
| 6 | 27275820 | Ectopic Expression of Testis Germ Cell Proteins in Cancer and Its Potential Role in Genomic Instability. | Int J Mol Sci | 2016 | https://conductscience.org/library/papers/27275820 | PubMed |
| 7 | 24787708 | Oncogenic functions of the cancer-testis antigen SSX on the proliferation, survival, and signaling pathways of cancer cells. | PLoS One | 2014 | https://conductscience.org/library/papers/24787708 | PubMed |
| 8 | 10781081 | Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses. | Proc Natl Acad Sci U S A | 2000 | https://conductscience.org/library/papers/10781081 | PubMed |
| 9 | 15316101 | MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to repress transcription. | Nucleic Acids Res | 2004 | https://conductscience.org/library/papers/15316101 | PubMed |
| 10 | 30333500 | The Cancer/Testes (CT) Antigen HORMAD1 promotes Homologous Recombinational DNA Repair and Radioresistance in Lung adenocarcinoma cells. | Sci Rep | 2018 | https://conductscience.org/library/papers/30333500 | PubMed |
| 11 | 17875943 | Epigenetic control of the immune escape mechanisms in malignant carcinomas. | Mol Cell Biol | 2007 | https://conductscience.org/library/papers/17875943 | PubMed |
| 12 | 7672823 | Involvement of two Ets binding sites in the transcriptional activation of the MAGE1 gene. | Immunogenetics | 1995 | https://conductscience.org/library/papers/7672823 | PubMed |
| 13 | 20534591 | Cancer/testis antigen CAGE exerts negative regulation on p53 expression through HDAC2 and confers resistance to anti-cancer drugs. | J Biol Chem | 2010 | https://conductscience.org/library/papers/20534591 | PubMed |
| 14 | 34880251 | Growth differentiation factor 1-induced tumour plasticity provides a therapeutic window for immunotherapy in hepatocellular carcinoma. | Nat Commun | 2021 | https://conductscience.org/library/papers/34880251 | PubMed |
| 15 | 30602372 | PRAME promotes epithelial-to-mesenchymal transition in triple negative breast cancer. | J Transl Med | 2019 | https://conductscience.org/library/papers/30602372 | PubMed |
| 16 | 12130538 | G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. | Genes Dev | 2002 | https://conductscience.org/library/papers/12130538 | PubMed |
| 17 | 270702 | Detection of antibody to autologous human leukemia cells by immune adherence assays. | Proc Natl Acad Sci U S A | 1977 | https://conductscience.org/library/papers/270702 | PubMed |
| 18 | 15252201 | Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humans. | Proc Natl Acad Sci U S A | 2004 | https://conductscience.org/library/papers/15252201 | PubMed |
| 19 | 34966825 | TEX10 Promotes the Tumorigenesis and Radiotherapy Resistance of Urinary Bladder Carcinoma by Stabilizing XRCC6. | J Immunol Res | 2021 | https://conductscience.org/library/papers/34966825 | PubMed |
| 20 | 10607842 | A human sex-chromosomal gene family expressed in male germ cells and encoding variably charged proteins. | Hum Mol Genet | 2000 | https://conductscience.org/library/papers/10607842 | PubMed |
Cited by47
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42780548 | The SPA17-AXL axis drives melanoma aggressiveness and SPA17-targeting vaccination exhibits antitumor efficacy. | Front Immunol | 2026 | https://conductscience.org/library/papers/42780548 | PubMed |
| 42753002 | Cancer-Testis Antigens in Immuno Oncology Mechanisms Therapeutic Strategies and Clinical Perspectives. | J Immunol Res | 2026 | https://conductscience.org/library/papers/42753002 | PubMed |
| 42690554 | Pan-cancer analysis identifies ODF2 as a dual prognostic and predictive biomarker for immunotherapy. | Discov Oncol | 2026 | https://conductscience.org/library/papers/42690554 | PubMed |
| 42416032 | Epigenetic Reprogramming with DNMT Inhibitors: A Multi-Mechanistic Approach to Enhance Immunotherapy in Glioblastoma. | J Cancer Immunol (Wilmington) | 2025 | https://conductscience.org/library/papers/42416032 | PubMed |
| 42239378 | The RNA helicase DDX53 (CAGE) contributes to RNA metabolism in a human germ cell model. | bioRxiv | 2026 | https://conductscience.org/library/papers/42239378 | PubMed |
| 42045541 | Advances in cancer immunotherapy: adoptive cell therapy and immune cell engagers in solid tumours. | Br J Cancer | 2026 | https://conductscience.org/library/papers/42045541 | PubMed |
| 41968569 | Immunohistochemical Analysis of Potential Therapeutic Targets PRAME, FOLR1, and CLDN18.2 in Salivary Gland Carcinomas. | Cancer Med | 2026 | https://conductscience.org/library/papers/41968569 | PubMed |
| 41877380 | ODF3B Promotes the Progression of Clear Cell Renal Cell Carcinoma via the JAK/STAT Signaling Pathway. | Med Sci Monit | 2026 | https://conductscience.org/library/papers/41877380 | PubMed |
| 41814007 | Clinical development of cancer vaccines. | Nat Med | 2026 | https://conductscience.org/library/papers/41814007 | PubMed |
| 41791790 | Integrating interferon gamma receptor pathways, antigenicity, and immune contexture as predictors of immunotherapeutic strategies for mucosal melanomas. | J Immunother Cancer | 2026 | https://conductscience.org/library/papers/41791790 | PubMed |
| 41732172 | Proteome-scale autoantibody profiling in PSC: Associations with clinical phenotypes and evidence for neuroendocrine deregulations. | JHEP Rep | 2026 | https://conductscience.org/library/papers/41732172 | PubMed |
| 41309872 | In silico design of a multi-epitope vaccine against the triple negative breast cancer. | Sci Rep | 2025 | https://conductscience.org/library/papers/41309872 | PubMed |
| 41158756 | Druggable target ATAD2 enhances the malignant progression and cooperates with E2F1 to up-regulate PDK1 expression in glioma. | Genes Dis | 2026 | https://conductscience.org/library/papers/41158756 | PubMed |
| 41099151 | Cancer-testis antigen ACRBP: Cytotoxic response to its HLA-A2 restricted peptide and immune features in ovarian cancer. | Hum Vaccin Immunother | 2025 | https://conductscience.org/library/papers/41099151 | PubMed |
| 41009820 | Nodal Spread Prediction in Human Oral Tongue Squamous Cell Carcinoma Using a Cancer-Testis Antigen Genes Signature. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41009820 | PubMed |
| 41009526 | Investigating Germ Cell Transition Genes in Breast Cancer: Exploring the Genesis of Cancer Testis-Associated Markers. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41009526 | PubMed |
| 40953013 | Epigenetic relay: Polycomb-directed DNA methylation in mammalian development. | PLoS Genet | 2025 | https://conductscience.org/library/papers/40953013 | PubMed |
| 40940897 | A Polyomavirus-Positive Merkel Cell Carcinoma Mouse Model Supports a Unified Origin for Somatic and Germ Cell Cancers. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40940897 | PubMed |
| 40868240 | Therapeutic Opportunities in Melanoma Through PRAME Expression. | Biomedicines | 2025 | https://conductscience.org/library/papers/40868240 | PubMed |
| 40810970 | Adoptive T-Cell Therapy in Sarcomas. | Curr Oncol Rep | 2025 | https://conductscience.org/library/papers/40810970 | PubMed |
Genes115
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36980267
GET https://conductscience.org/api/papers/v1/36980267/references?page=2